This study aims to examine whether there was a difference in the concentrations of IL-1β, IL-2, IL-6, and IL-10 between the patients experiencing a first episode of psychosis who have not previously been treated with antipsychotics and the healthy controls, as well as to determine the potential association of these biomarkers with the intensity and structure of the clinical presentation as assessed by the PANSS scale. This evidence concerns the gene IL6 and psychotic disorder.